Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bunce

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
Tissue Antigens|October 24, 2002
High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibilityT Ahmad, S E Marshall, K Mulcahy-Hawes, et al.
Mutation Research|January 24, 2009
The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesisJane Birtwistle, Rachel E Hayden, Farhat L Khanim, et al.
Rheumatology (Oxford, England)|April 19, 2002
Immune responses to native beta(2)-glycoprotein I in patients with systemic lupus erythematosus and the antiphospholipid syndromeM L Davies, S P Young, K Welsh, et al.
British Journal of Cancer|July 21, 2017
Active multiple myeloma suppresses and typically eliminates coexisting MGUSJohn P Campbell, Jennifer L J Heaney, Sankalp Pandya, et al.
Journal of Virology|January 11, 2001
Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assaysP J Goulder, M M Addo, M A Altfeld, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 5, 2005
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropicsElizabeth J Meredith, Michelle J Holder, Anita Chamba, et al.
The Lancet. Haematology|November 18, 2017
Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort studyJohn P Campbell, Jennifer L J Heaney, Sankalp Pandya, et al.
Immunology Letters|October 12, 2001
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variationP J Goulder, C Pasquier, E C Holmes, et al.
Plos One|July 7, 2023
Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activationSandro Trova, Fei Lin, Santosh Lomada, et al.
Journal of Oncology Practice|September 1, 2016
Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care DeliveryJulia R Trosman, Ruth C Carlos, Melissa A Simon, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Tissue Antigens|October 24, 2002
High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibilityT Ahmad, S E Marshall, K Mulcahy-Hawes, et al.
Mutation Research|January 24, 2009
The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesisJane Birtwistle, Rachel E Hayden, Farhat L Khanim, et al.
Rheumatology (Oxford, England)|April 19, 2002
Immune responses to native beta(2)-glycoprotein I in patients with systemic lupus erythematosus and the antiphospholipid syndromeM L Davies, S P Young, K Welsh, et al.
British Journal of Cancer|July 21, 2017
Active multiple myeloma suppresses and typically eliminates coexisting MGUSJohn P Campbell, Jennifer L J Heaney, Sankalp Pandya, et al.
Journal of Virology|January 11, 2001
Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assaysP J Goulder, M M Addo, M A Altfeld, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 5, 2005
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropicsElizabeth J Meredith, Michelle J Holder, Anita Chamba, et al.
The Lancet. Haematology|November 18, 2017
Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort studyJohn P Campbell, Jennifer L J Heaney, Sankalp Pandya, et al.
Immunology Letters|October 12, 2001
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variationP J Goulder, C Pasquier, E C Holmes, et al.
Plos One|July 7, 2023
Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activationSandro Trova, Fei Lin, Santosh Lomada, et al.
Journal of Oncology Practice|September 1, 2016
Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care DeliveryJulia R Trosman, Ruth C Carlos, Melissa A Simon, et al.
Pageof 21